OTC · IDXG
Interpace Biosciences, Inc.
$5.72+$0.77 (+15.56%)
Interpace Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.33% below the high.
Loading market information…
OTC · RNVA · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Rennova Health, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Rennova Health, Inc., through its various subsidiaries, provides medical services throughout the United States. As of December 31, 2021, the company's assets included an operational hospital situated in Oneida, Tennessee; an acute care facility and an associated doctor's practice located in Jamestown, Tennessee; and a rural medical clinic in Williamsburg, Kentucky. The organization was founded in 2005 and has its principal office in West Palm Beach, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:07 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$5.72+$0.77 (+15.56%)
Interpace Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.33% below the high.
$0.06$0.00 (0.0%)
Reflect Scientific, Inc.’s quoted price sits in the upper half of its reported 52-week range, 17.24% below the high.
$0.03$0.00 (0.0%)
Cardiac Biotech Solutions Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
CA$0.05+CA$0.01 (+11.11%)
Avricore Health Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.01CA$0.00 (0.0%)
1933 Industries Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.05CA$0.00 (0.0%)
Telo Genomics Corp.’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
$0.01$0.00 (0.0%)
Stella Diagnostics Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.29% below the high.
$0.00$0.00 (0.0%)
REMSleep Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.22% below the high.
